German TAVI-Register
Study Details
Study Description
Brief Summary
The TAVI - Register is a Germany-wide scientific elevation in which data about the aortic valve treatment and the therapeutic consequences are documented.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Documentation of all consecutive patients of the participating centers with significant aortic stenosis, undergoing one of the following therapies:
-
Percutaneous transfemoral aortic valve replacement
-
Percutaneous aortic valve replacement transapical
-
Percutaneous aortic valve replacement transaortic
-
Aortic valve balloon valvuloplasty
-
Surgical aortic valve replacement
-
Conservative treatment
-
Documentation of the indications, procedural results and clinical short-and long-term results of the above therapies
-
Documentation of operational risk and quality of life
-
Documentation of the technical implementation of the procedure and success of the intervention and of hospital reinterventions
-
Documentation of hospital mortality, nonfatal major complications (stroke, TIA, myocardial infarction, dialysis, vascular complications, bleeding, neuropsychological status)
-
Documentation of discharge medication and the length of hospital stay
-
Documentation of the serious long-term complications, including mortality, stroke, TIA, myocardial infarction, dialysis, the reintervention and quality of life and of drug therapy within 30 days, 1 year, 3 years and 5 years.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Aortic valve procedures percutaneous transfemoral aortic valve implantation percutaneous transapical aortic valve implantation percutaneous transaortic aortic valve implantation aortic valve valvuloplasty surgical aortic valve replacement conservative treatment |
Outcome Measures
Primary Outcome Measures
- All cause mortality [5 years]
Secondary Outcome Measures
- Short- and long-term results of the documented therapies [5 years]
Documentation of procedural results and clinical short-and long-term results of the documented therapies
- Details on operational risk [up to four weeks]
Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.
- Details of performed procedures [up to four weeks]
Documentation of the indications, the technical implementation of the procedures and success of the intervention and of possible hospital reinterventions. Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.
- Complications during hospital stay [up to four weeks]
Documentation of hospital mortality, nonfatal major complications (stroke, TIA, myocardial infarction, dialysis, vascular complications, bleeding, neuropsychological status). Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.
- Details of hospital stay [up to four weeks]
Documentation of e.g. drug treatment, discharge medication and the length of hospital stay. Data are not recorded at a fixed day, but are collected during the initial hospital stay and are submitted when the patient leaves the hospital.
- Serious long-term complications [5 years]
Documentation of the serious long-term complications, including mortality, stroke, TIA, myocardial infarction, dialysis and reinterventions
- Quality of life [5 years]
- Drug treatment [5 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
patients with aortic stenosis (degree III) who received one of the following therapies:
-
transapical operative aortic valve implantation
-
operative aortic valve implantation
-
percutaneous aortic valve implantation
-
balloon valvuloplasty
Exclusion Criteria:
- missing signed informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Institut fur Herzinfarktforschung Ludwigshafen | Ludwigshafen | RPF | Germany | 67063 |
Sponsors and Collaborators
- Stiftung Institut fuer Herzinfarktforschung
Investigators
- Principal Investigator: Jochen Senges, MD, Stiftung Insitut fuer Herzinfarktforschung
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- TAVI